Lawicki S - Search Results

1

Possible Diagnostic Application of CXCL12 and CXCR4 as Tumor Markers in Breast Cancer Patients.

Dąbrowska E, Przylipiak A, Zajkowska M, Piskor BM, Sidorkiewicz I, Szmitkowski M, Lawicki S. Dąbrowska E, et al. Among authors: lawicki s. Anticancer Res. 2020 Jun;40(6):3221-3229. doi: 10.21873/anticanres.14303. Anticancer Res. 2020. PMID: 32487616

2

Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.

Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M. Ławicki S, et al. Biomarkers. 2017 Mar;22(2):157-164. doi: 10.1080/1354750X.2016.1252955. Epub 2016 Nov 9. Biomarkers. 2017. PMID: 27775427

3

Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients.

Lubowicka E, Przylipiak A, Zajkowska M, Piskór BM, Malinowski P, Fiedorowicz W, Ławicki S. Lubowicka E, et al. Among authors: lawicki s. Biomed Res Int. 2018 Jul 30;2018:2124390. doi: 10.1155/2018/2124390. eCollection 2018. Biomed Res Int. 2018. PMID: 30151375 Free PMC article.

4

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.

Zajkowska M, Lubowicka E, Fiedorowicz W, Szmitkowski M, Jamiołkowski J, Ławicki S. Zajkowska M, et al. Among authors: lawicki s. Pathol Oncol Res. 2019 Oct;25(4):1477-1486. doi: 10.1007/s12253-018-0527-0. Epub 2018 Nov 1. Pathol Oncol Res. 2019. PMID: 30387014 Free PMC article.

5

Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer.

Zajkowska M, Lubowicka E, Malinowski P, Szmitkowski M, Ławicki S. Zajkowska M, et al. Among authors: lawicki s. Acta Biochim Pol. 2018 Dec 13;65(4):621-628. doi: 10.18388/abp.2018_2713. Acta Biochim Pol. 2018. PMID: 30543720 Free article.

6

Diagnostic Power of Selected Cytokines, MMPs and TIMPs in Ovarian Cancer Patients - ROC Analysis.

Będkowska GE, Piskór B, Gacuta E, Zajkowska M, Osada J, Szmitkowski M, Dąbrowska M, Ławicki S. Będkowska GE, et al. Among authors: lawicki s. Anticancer Res. 2019 May;39(5):2575-2582. doi: 10.21873/anticanres.13380. Anticancer Res. 2019. PMID: 31092455

7

Plasma Levels and Tissue Expression of Selected Cytokines, Metalloproteinases and Tissue Inhibitors in Patients With Cervical Cancer.

Sidorkiewicz I, Piskór B, Dąbrowska E, Guzińska-Ustymowicz K, Pryczynicz A, Zbucka-Krętowska M, Ławicki S. Sidorkiewicz I, et al. Among authors: lawicki s. Anticancer Res. 2019 Nov;39(11):6403-6412. doi: 10.21873/anticanres.13854. Anticancer Res. 2019. PMID: 31704874

8

Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?

Zajkowska M, Gacuta E, Lubowicka E, Szmitkowski M, Ławicki S. Zajkowska M, et al. Among authors: lawicki s. Acta Biochim Pol. 2020 Mar 11;67(1):25-29. doi: 10.18388/abp.2020_2873. Acta Biochim Pol. 2020. PMID: 32160452 Free article.

9

C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients.

Dąbrowska E, Przylipiak A, Zajkowska M, Piskór BM, Borowik-Zaręba A, Ławicki S. Dąbrowska E, et al. Among authors: lawicki s. Acta Biochim Pol. 2020 Nov 27;67(4):539-449. doi: 10.18388/abp.2020_5402. Acta Biochim Pol. 2020. PMID: 33245226 Free article.

10

[Cytokines as tumor markers in breast cancer].

Ławicki S, Mroczko B, Szmitkowski M. Ławicki S, et al. Postepy Hig Med Dosw. 2003;57(4):455-63. Postepy Hig Med Dosw. 2003. PMID: 14626202 Review. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters